☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Deciphera
Deciphera Presents Results of Qinlock (ripretinib) in P-III (INTRIGUE) Study for the Treatment of Gastrointestinal Stromal Tumor a...
January 25, 2022
PharmaShots Interview: Deciphera's Mathew L. Sherman Shares Insight on Data of QINLOCK and DCC-3014 Presented at CTOS 2020
February 17, 2021
Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20
June 1, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
